New GARD® data on agrochemical formulations, fragrance materials, medical devices and metals - Skin sensitization: using in vitro tools for quantitative potency assessment as an alternative to the Local Lymph Node Assay In case you missed SenzaGen’s scientific session at this year’s SOT, here is a new opportunity! Together with guest speakers from Takasago and […]
Case studies on 3D reconstructed human tissues This webinar will showcase the opportunities offered by 3D reconstructed human tissues to demonstrate the physical mode of action of medical devices in line with the requirements and ethical criteria of the EU Medical Devices Regulation (MDR) 2017/745. Key takeaways Attendees will gain insights into: 💡 How the principles […]
Join this live webinar led by our skin sensitization specialist Dr Andy Forreryd to learn the features and benefits of GARDskin and how the method can be used to fill data gaps during regulatory testing and product development. GARDskin approved by OECD We are delighted to announce that SenzaGen's GARDskin assay has been adopted by […]
Drug device combination products and substance-based medical devices Sep 14 | Copenhagen, Denmark Medicon Valley Alliance, together with member company Innokas Medical, have the pleasure to invite you to the Medicon Valley Alliance MedTech Network meeting, on the 14th of September, focusing on drug-device combination products and substance-based medical devices. Sign up here The market […]
2022 International Congress of Toxicology - "Uniting in Toxicology" Discussions at this year's ICT New opportunities for skin sensitization testing with GARDskin OECD TG 442E Come visit us at our booth and join our industry symposium to learn how the high performance and broad applicability of the GARDskin method bring new opportunities to the field […]
Oct 5-6 | Copenhagen, Denmark Meet SenzaGen at 2022 Biocompatibility Matters, a two-day conference in Copenhagen. SenzaGen's Medical Device specialist and ISO expert Dr Rose-Marie Jenvert will speak on the topic “New approaches to in vitro sensitization – regulatory acceptance”. Key takeaways: * An introduction to in vitro assays for skin sensitization, ISO 10993-10 * […]
New GARD® data on agrochemicals,"difficult-to-test" substances and potency assessments - In vitro skin sensitization testing: New opportunities for hazard and quantitative potency assessment using genomics and machine learning technology In case you missed SenzaGen’s scientific session at this year’s ICT, we are pleased to offer you a new opportunity! We will present new scientific data […]
Oct 19-21 | Chapel Hill, N.C.,USA More information coming soon!
In this webinar, our Medical Device and ISO expert Dr Rose-Marie Jenvert will tell you more about how you can use in vitro methods for the biological evaluation of medical devices, now offered at our GLP-certified laboratories. She will also introduce you to our expanded medical device offering and how we can help you to […]
Booth#5 | Nov 21-25 | Sitges (Barcelona), Spain Are you attending the 2022 ESTIV International Congress? Come meet us at our booth and join our scientific sessions to hear the latest news about GARD and how the assays are used for skin sensitization testing. We will also introduce you to our expanded services for in […]
